Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis

Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant tuberculosis (MDR-TB) treatment failure. M. tuberculosis strains resistant to isoniazid and rifampin are defined as MDR-TB. In recent years, resistance to LNZ among MDR-TB cases has been reported in s...

Full description

Bibliographic Details
Main Authors: Taher Azimi, Saeed Khoshnood, Arezoo Asadi, Mohsen Heidary, Hassan Mahmoudi, Vahab Hassan Kaviar, Masoume Hallajzadeh, Mohammad Javad Nasiri
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
tuberculosis
meta-analysis
linezolid
TB
MDR-TB
resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.955050/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.955050/full

Similar Items